Clinical Cancer Research, Vol 2, Issue 1 175-180, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications

A Bellacosa, G Almadori, S Cavallo, G Cadoni, J Galli, G Ferrandina, G Scambia and G Neri
Institutes of Medical Genetics, Otorhinolaryngology, and Obstetrics and Gynecology, Catholic University Medical School, Largo F. Vito 1, 00168 Rome, Italy.

The cyclin D1 (CCND1) gene is amplified, rearranged, and overexpressed frequently in human cancer, including squamous cell carcinoma. The gene dosage of CCND1 was examined in 51 primary laryngeal squamous cell carcinomas, and amplification of the gene was found in 9 (17.6%) cases. CCND1 amplification did not correlate with age, tumor localization and extension, cervical lymph node involvement, histopathological grading, and epidermal growth factor receptor levels. In a univariate analysis, CCND1 amplification, tumor extension, lymph node involvement, poor histological differentiation, and high epidermal growth factor receptor levels were correlated significantly with shorter overall survival. In a median follow-up period of 29 months, the overall survival rate was 71.4% for patients affected with tumors displaying a normal CCND1 dosage and only 25.0% for patients affected with tumors carrying amplified CCND1 (P = 0.0288). In a multivariate analysis, only CCND1 and tumor extension retained statistically significant prognostic values (P = 0.037 and 0.041, respectively). This is the first report in which CCND1 amplification is identified as a significant independent prognostic factor in laryngeal carcinoma. Evaluation of CCND1 amplification could be applicable to the clinical management of laryngeal cancer, allowing identification of patients with poor prognoses.

This article has been cited by other articles:

				A. Celetti, D. Testa, S. Staibano, F. Merolla, V. Guarino, M. D. Castellone, R. Iovine, G. Mansueto, P. Somma, G. De Rosa, et al. Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal Squamous Cell Carcinomas and Enhances Carcinoma Cell Proliferation and Invasiveness Clin. Cancer Res., November 15, 2005; 11(22): 8019 - 8027. [Abstract] [Full Text] [PDF]

				Z. Yu, P. M. Weinberger, B. G. Haffty, C. Sasaki, C. Zerillo, J. Joe, D. Kowalski, J. Dziura, R. L. Camp, D. L. Rimm, et al. Cyclin D1 Is a Valuable Prognostic Marker in Oropharyngeal Squamous Cell Carcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1160 - 1166. [Abstract] [Full Text] [PDF]

				L. H. Kalish, R. A. Kwong, I. E. Cole, R. M. Gallagher, R. L. Sutherland, and E. A. Musgrove Deregulated Cyclin D1 Expression Is Associated with Decreased Efficacy of the Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cell Lines Clin. Cancer Res., November 15, 2004; 10(22): 7764 - 7774. [Abstract] [Full Text] [PDF]

				V. B. Wreesmann, W. Shi, H. T. Thaler, A. Poluri, D. H. Kraus, D. Pfister, A. R. Shaha, J. P. Shah, P. H. Rao, and B. Singh Identification of Novel Prognosticators of Outcome in Squamous Cell Carcinoma of the Head and Neck J. Clin. Oncol., October 1, 2004; 22(19): 3965 - 3972. [Abstract] [Full Text] [PDF]

				G. Almadori, G. Cadoni, P. Cattani, J. Galli, F. Bussu, G. Ferrandina, G. Scambia, G. Fadda, and M. Maurizi Human Papillomavirus Infection and Epidermal Growth Factor Receptor Expression in Primary Laryngeal Squamous Cell Carcinoma Clin. Cancer Res., December 1, 2001; 7(12): 3988 - 3993. [Abstract] [Full Text] [PDF]

				S.-C. Liu, S. Y. Zhang, J. S. Babb, J. A. Ridge, and A. J. P. Klein-Szanto Image Cytometry of Cyclin D1: A Prognostic Marker for Head and Neck Squamous Cell Carcinomas Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 455 - 459. [Abstract] [Full Text]

				B. D. Smith, G. L. Smith, D. Carter, C. T. Sasaki, and B. G. Haffty Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell Carcinoma J. Clin. Oncol., May 10, 2000; 18(10): 2046 - 2052. [Abstract] [Full Text] [PDF]

				E. Brambilla, S. Gazzeri, D. Moro, S. Lantuejoul, S. Veyrenc, and C. Brambilla Alterations of Rb Pathway (Rb-p16INK4-Cyclin D1) in Preinvasive Bronchial Lesions Clin. Cancer Res., February 1, 1999; 5(2): 243 - 250. [Abstract] [Full Text] [PDF]